Browsing: Wuhan YZY Biopharma Co Ltd

A biotechnology company dedicated to developing BsAb-based therapies in China, YZY Biopharma Officially Listed on Main Board of SEHK

By Marie JonesSeptember 25, 20230

Wuhan YZY Biopharma Co., Ltd. (YZY Biopharma or the Company, together with its subsidiaries, the Group, HKG: 2496), is officially…

Focusing on the development of BsAbs in China, YZY Biopharma Announces Proposed Listing on the Main Board of SEHK

By Marie JonesSeptember 13, 20230

Offer price between HK$16 and HK$20 per H Share Wuhan YZY Biopharma Co., Ltd. (YZY Biopharma or the Company, together…